When federal regulators last week approved Digene Corp.'s cervical cancer test as a primary screening tool for women over 30, they catapulted what had been a follow-up test into direct competition ...

Digene Corp., which makes a screening test for cervical cancer, said yesterday that it had struck a deal with a Texas biotech company to sell a genetic test for identifying carriers of cystic fibrosis ...

“Finding a cure for cancer” is synonymous in our society with the ultimate in success. And yet Digene (DIGE $37), which sells a test that could eradicate cervical cancer, meets with tepid enthusiasm ...

NEW YORK, Jan 12 (Reuters) - Digene Corp's new chief executive officer said on Friday the company could not afford to remain "a one-product company" and would aim to disclose a strategy of moving ...